These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17343369)

  • 1. Ovarian cancer activity of cyclic amine and thiaether metal complexes.
    Medvetz DA; Stakleff KD; Schreiber T; Custer PD; Hindi K; Panzner MJ; Blanco DD; Taschner MJ; Tessier CA; Youngs WJ
    J Med Chem; 2007 Apr; 50(7):1703-6. PubMed ID: 17343369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arene ruthenium complexes as anticancer agents.
    Süss-Fink G
    Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumoral activity of non-platinum xanthate complexes.
    Friebolin W; Schilling G; Zöller M; Amtmann E
    J Med Chem; 2005 Dec; 48(25):7925-31. PubMed ID: 16335917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and in vitro evaluation of a potentially selective anticancer, mixed-metal [ruthenium(III)-platinum(II)] trinuclear complex.
    Herman A; Tanski JM; Tibbetts MF; Anderson CM
    Inorg Chem; 2008 Jan; 47(1):274-80. PubMed ID: 18062685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.
    Habtemariam A; Melchart M; Fernandez R; Parsons S; Oswald ID; Parkin A; Fabbiani FP; Davidson JE; Dawson A; Aird RE; Jodrell DI; Sadler PJ
    J Med Chem; 2006 Nov; 49(23):6858-68. PubMed ID: 17154516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells.
    Barve V; Ahmed F; Adsule S; Banerjee S; Kulkarni S; Katiyar P; Anson CE; Powell AK; Padhye S; Sarkar FH
    J Med Chem; 2006 Jun; 49(13):3800-8. PubMed ID: 16789737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
    Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
    J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA binding studies of novel Copper(II) complexes containing L-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells.
    Chauhan M; Banerjee K; Arjmand F
    Inorg Chem; 2007 Apr; 46(8):3072-82. PubMed ID: 17378549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
    Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
    Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure and antitumor activity of [RhCl3(N-N)(DMSO)] polypyridyl complexes.
    Sliwińska U; Pruchnik FP; Pelińska I; Ułaszewski S; Wilczok A; Zajdel A
    J Inorg Biochem; 2008 Oct; 102(10):1947-51. PubMed ID: 18718669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
    Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
    J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioamido coordination in a thioxo-1,2,4-triazole copper(II) complex enhances nonapoptotic programmed cell death associated with copper accumulation and oxidative stress in human cancer cells.
    Tardito S; Bussolati O; Maffini M; Tegoni M; Giannetto M; Dall'asta V; Franchi-Gazzola R; Lanfranchi M; Pellinghelli MA; Mucchino C; Mori G; Marchio L
    J Med Chem; 2007 Apr; 50(8):1916-24. PubMed ID: 17373781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach for the preparation of efficient DNA cleaving agents: ditopic copper-platinum complexes based on 3-Clip-Phen and cisplatin.
    Hoog Pd; Boldron C; Gamez P; Sliedregt-Bol K; Roland I; Pitié M; Kiss R; Meunier B; Reedijk J
    J Med Chem; 2007 Jun; 50(13):3148-52. PubMed ID: 17521178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis, spectral studies and antitumor activity.
    Rocha FV; Barra CV; Netto AV; Mauro AE; Carlos IZ; Frem RC; Ananias SR; Quilles MB; Stevanato A; da Rocha MC
    Eur J Med Chem; 2010 May; 45(5):1698-702. PubMed ID: 20116142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal-NHC complexes: a survey of anti-cancer properties.
    Teyssot ML; Jarrousse AS; Manin M; Chevry A; Roche S; Norre F; Beaudoin C; Morel L; Boyer D; Mahiou R; Gautier A
    Dalton Trans; 2009 Sep; (35):6894-902. PubMed ID: 20449127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
    Waern JB; Dillon CT; Harding MM
    J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.